Published January 23, 2024
0 views Other Open Access Open Access

HIV drug resistance to integrase inhibitors in low- and middle-income countries.

  • 1. Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
  • 2. Faculty of Health Sciences, University of Buea, Buea, Cameroon.
  • 3. National HIV Drug Resistance Group, Ministry of Public Health, Yaoundé, Cameroon.
  • 4. Faculty of Medicine and Biomedical Sciences, University of Yaoundé-I, Yaoundé, Cameroon.
  • 5. Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
  • 6. UNESCO Board of Biotechnology, University of Rome Tor Vergata, Rome, Italy.
  • 7. University of Rome Tor Vergata
  • 8. Bambino Gesù IRCCS Pediatric Hospital, Rome, Italy.
  • 9. Scientific Institute for Research, Hospitalization and Healthcare
  • 10. Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.
  • 11. Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia. nicaise.ndembi@ihv.umaryland.edu.
  • 12. Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA. nicaise.ndembi@ihv.umaryland.edu.
  • 13. Kanazawa University, Graduate School of Medical Sciences, Ishikawa, Japan. nicaise.ndembi@ihv.umaryland.edu.
  • 14. Kanazawa University
Enabled by The Lens

Open Access

Publisher Website Access full text